Polyflex® (ampicillin for injectable suspension)

Manufacturer
Boehringer Ingelheim Animal Health USA Inc.
Effective date
2024-09-17
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
10
Source
full-release
Hydrated at
2026-06-01 02:43:30

Label at a glance#

ProductPOLYFLEX
Active ingredientAMPICILLIN TRIHYDRATE
Label structure15 sections

Dosage and administration

The multi-dose dry-filled vials should be reconstituted to the desired concentration by adding the required amount of Sterile Water for Injection, USP, according to label directions. SHAKE WELL. The appearance will be white to pale yellow in color. At the time of reconstitution the vial should be dated and the concentration noted on the label.

Storage and handling

Store at or below 25°C (77°F) with excursions permitted up to 30°C (86°F). After reconstitution, store under refrigeration. Use within 3 months of first puncture. Avoid freezing.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

For veterinary use only

CAUTION:

SPL UNCLASSIFIED SECTION

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION:

DESCRIPTION SECTION

POLYFLEX (ampicillin for injectable suspension) is a broad-spectrum penicillin which has bactericidal activity against a wide range of common gram-positive and gram-negative bacteria.

Each 25 g vial contains: 25 g ampicillin activity as ampicillin trihydrate, 90 mg methylparaben (as preservative), 10 mg propylparaben (as preservative), 200 mg lecithin, 500 mg povidone, 200 mg sodium chloride, 600 mg sodium citrate anhydrous.

INDICATIONS:

VETERINARY INDICATIONS SECTION

POLYFLEX has proved effective in the treatment of many infections previously beyond the spectrum of penicillin therapy. This drug is particularly indicated in the treatment of the following infections caused by susceptible strains of organisms:

Dogs and Cats — Respiratory Tract Infections: Upper respiratory infections, tonsillitis and bronchopneumonia due to hemolytic streptococci, Staphylococcus aureus, Escherichia coli,

Proteus mirabilis and Pasteurella spp.

Urinary Tract Infections due to Proteus mirabilis, Escherichia coli, Staphylococcus spp., hemolytic streptococci and Enterococcus spp.

Gastrointestinal Infections due to Enterococcus spp., Staphylococcus spp. and Escherichia coli.

Skin, Soft Tissue and Post-Surgical Infections: Abscesses, pustular dermatitis, cellulitis and infections of the anal gland, due to Escherichia coli, Proteus mirabilis, hemolytic streptococci, Staphylococcus spp. and Pasteurella spp.

Cattle and Calves Including Non-Ruminating (Veal Calves) — Respiratory Tract Infections:

Bacterial pneumonia (shipping fever, calf pneumonia and bovine pneumonia) caused by Aerobacter spp., Klebsiella spp., Staphylococcus spp., Streptococcus spp., Pasteurella multocida and E. coli susceptible to ampicillin trihydrate.

DOSAGE:

DOSAGE & ADMINISTRATION SECTION

The dosage of POLYFLEX will vary according to the animal being treated, the severity of the infection and the animal’s response.

Dogs and Cats — The recommended dose for dogs or cats is 3 mg/lb of body weight administered twice daily by subcutaneous or intramuscular injection.

Cattle and Calves Including Non-Ruminating (Veal Calves) — From 2 mg to 5 mg/lb of body weight once daily by intramuscular injection. Do not treat for more than 7 days.

In all species, 3 days treatment is usually adequate, but treatment should be continued for 48 to 72 hours after the animal has become afebrile or asymptomatic.

DIRECTIONS FOR USE:

DOSAGE & ADMINISTRATION SECTION

The multi-dose dry-filled vials should be reconstituted to the desired concentration by adding the required amount of Sterile Water for Injection, USP, according to label directions. SHAKE WELL.

The appearance will be white to pale yellow in color.

At the time of reconstitution the vial should be dated and the concentration noted on the label.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

A history of allergic reactions to penicillin, cephalosporins or their analogues should be considered a contraindication for the use of this agent.

RESIDUE WARNINGS:

RESIDUE WARNING SECTION

Do not treat cattle for more than 7 days. Milk from treated cows must not be used for food during treatment, and for 48 hours (4 milkings) after the last treatment. Cattle must not be slaughtered for food during treatment, and for 144 hours (6 days) after the last treatment.

PRECAUTIONS:

PRECAUTIONS SECTION

Because it is a derivative of 6-aminopenicillanic acid, POLYFLEX has the potential for producing allergic reactions. If they should occur, POLYFLEX should be discontinued and the subject treated with the usual agents (antihistamines, pressor amines, corticosteroids).

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

The antimicrobial action of ampicillin is bactericidal, and only a small percentage of the antibiotic is serum-bound. Peak serum levels in dogs and cats are reached approximately one-half hour following subcutaneous or intramuscular injection, and in cattle 1 hour to 2 hours following intramuscular injection.

In vitro studies have demonstrated sensitivity of the following organisms to ampicillin: gram-positive bacteria – alpha- and beta-hemolytic streptococci, staphylococci (non-penicillinase-producing), Bacillus anthracis and most strains of enterococci and clostridia; gram-negative bacteria – Proteus mirabilis, E. coli and many strains of Salmonella and Pasteurella multocida.

The drug does not resist destruction by penicillinase and, hence, is not effective against strains of staphylococci resistant to penicillin G. Susceptibility tests should be conducted to estimate the in vitro susceptibility of bacterial isolates to ampicillin.

STORAGE:

STORAGE AND HANDLING SECTION

Store at or below 25°C (77°F) with excursions permitted up to 30°C (86°F). After reconstitution, store under refrigeration. Use within 3 months of first puncture. Avoid freezing.

HOW SUPPLIED:

HOW SUPPLIED SECTION

POLYFLEX (ampicillin for injectable suspension) is supplied in vials containing 25 g ampicillin activity as ampicillin trihydrate.

NDC 0010-4712-02 — 25 g per vial

SPL UNCLASSIFIED SECTION

POLYFLEX® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.

© 2020 Boehringer Ingelheim Animal Health USA Inc. All rights reserved.

Approved by FDA under NADA # 055-030

Marketed by:

Boehringer Ingelheim Animal Health USA Inc.

Duluth, GA 30096

Made in Italy

Rev. 9/2020
471209-01

Principal Display Panel – 25 g Vial Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0010-4712-02

Polyflex®

(ampicillin for injectable suspension)

For veterinary use only

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Equivalent to 25 g Ampicillin

Approved by FDA under NADA # 055-030

Picture of 25g vial label
Picture of 25g vial label

Principal Display Panel - 25 g Display Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0010-4712-02

Polyflex®

(ampicillin for injectable suspension)

For veterinary use only

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Equivalent to 25 g Ampicillin

Approved by FDA under NADA # 055-030

Picture of 25 g display carton
Picture of 25 g display carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2281872ampicillin 250 MG/mL Injectable SuspensionPSN10
1044196ampicillin 250 MG/ML Injectable Suspension [Polyflex]SBD10
2281872ampicillin 250 MG/ML Injectable SuspensionSCD10
1044196Polyflex 10 GM per vial Injectable SuspensionSY10
1044196Polyflex 250 MG/ML Injectable SuspensionSY10

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fd9d6ee0-43ae-43c7-aa52-3d5a936186d6Product name120250722
4fe9b92f-7dcd-4058-8def-e75f4dcd5ab3Product name220160201
c9385d77-2af7-47a4-bc97-1127e71caf9bProduct name320160201
05b6b9ae-4ba4-27ee-4c8c-f72b41de3815Product name520151207
b353113e-7b3d-4b1f-a286-b96a3a5eac85Product name320151026
8c59be9b-72b0-49e8-b7ef-1a80c10599deProduct name320150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0010-4712-02POLYFLEX79 mL in 1 VIALINJECTION, POWDER, FOR SUSPENSIO7910

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0010-4712POLYFLEX (AMPICILLIN) INJECTION, POWDER, FOR SUSPENSION [BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.]101 package rows20240919_61be8261-ac3d-418a-a414-62c64d9eacc0.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AMPICILLIN TRIHYDRATEACTIVE INGREDIENTHXQ6A1N7R63
AMPICILLINACTIVE MOIETY7C782967RD3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0010-47120010-4712-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.